RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Umlaut.Bio

Umlaut.Bio

Umlaut.Bio is a spinout of the EMBL, is pursuing tRNA targets for treatment of cancer and immunological diseases.

Latest funding

$3.46M Pre Seed ·

Source: N24 Haber

Funding history ↓
Website: umlaut.bio.
GitHub: typekit.
LinkedIn: umlaut-bio.
Category: Health and bio.
Stage: Pre Seed.
Based in: Heidelberg, Germany.
Last round: Feb 20, 2026 · 275 days ago.
On Recent Funding since: Oct 2, 2026.

Signals

Website registeredMay 13, 2022 (4 years old)

Funding rounds

DateRoundAmountLeadSource
Pre Seed$3.46M—N24 Haber

Timeline

  1. Website created

Companies like Umlaut.Bio

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/umlaut-bio (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy